These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25674245)

  • 1. Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.
    Long XH; Zhao K; Zhang GM; Zhou Y; Zhou RP; Liu ZL; Zhang ZH
    Int J Clin Exp Pathol; 2014; 7(12):8777-83. PubMed ID: 25674245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma.
    Wang H; Luo QF; Peng AF; Long XH; Wang TF; Liu ZL; Zhang GM; Zhou RP; Gao S; Zhou Y; Chen WZ
    Int J Mol Med; 2014 Mar; 33(3):633-9. PubMed ID: 24366211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
    Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
    Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.
    Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ
    Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration.
    Liu ZL; Zhou Y; Luo QF; Hu M; Wang G; Huang SH; Shu Y
    Indian J Pathol Microbiol; 2012; 55(2):163-9. PubMed ID: 22771636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
    Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
    Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.
    Yan C; Wei H; Minjuan Z; Yan X; Jingyue Y; Wenchao L; Sheng H
    PLoS One; 2014; 9(5):e97697. PubMed ID: 24866893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "HER2-PI3K/Akt-FASN Axis" regulated malignant phenotype of colorectal cancer cells.
    Li N; Bu X; Wu P; Wu P; Huang P
    Lipids; 2012 Apr; 47(4):403-11. PubMed ID: 22218925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of fatty acid synthase inhibits the "HER2-PI3K/Akt axis" activity and malignant phenotype of Caco-2 cells.
    Li N; Lu H; Chen C; Bu X; Huang P
    Lipids Health Dis; 2013 Jun; 12():83. PubMed ID: 23725225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma.
    Sun T; Zhong X; Song H; Liu J; Li J; Leung F; Lu WW; Liu ZL
    Cell Death Dis; 2019 Apr; 10(4):298. PubMed ID: 30931932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells.
    Lee JS; Sul JY; Park JB; Lee MS; Cha EY; Song IS; Kim JR; Chang ES
    Phytother Res; 2013 May; 27(5):713-20. PubMed ID: 22767439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
    Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
    Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells.
    Bessadóttir M; Skúladóttir EÁ; Gowan S; Eccles S; Ögmundsdóttir S; Ogmundsdóttir HM
    Phytomedicine; 2014 Oct; 21(12):1717-24. PubMed ID: 25442282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells.
    Fu D; Liu S; Liu J; Chen W; Long X; Chen X; Zhou Y; Zheng Y; Huang S
    J Clin Lab Anal; 2021 Mar; 35(3):e23653. PubMed ID: 33405298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
    Corominas-Faja B; Vellon L; Cuyàs E; Buxó M; Martin-Castillo B; Serra D; García J; Lupu R; Menendez JA
    Histol Histopathol; 2017 Jul; 32(7):687-698. PubMed ID: 27714708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.
    Vazquez-Martin A; Colomer R; Brunet J; Lupu R; Menendez JA
    Cell Prolif; 2008 Feb; 41(1):59-85. PubMed ID: 18211286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of fatty acid synthase and adipocyte fatty acid-binding protein and the relationship with the clinicopathological characteristics in human infiltrating ductal breast cancer].
    Zhou L; Zhao YH; Wang XD; Jiang SF; Li H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):228-33. PubMed ID: 25924435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.
    Blancafort A; Giró-Perafita A; Oliveras G; Palomeras S; Turrado C; Campuzano Ò; Carrión-Salip D; Massaguer A; Brugada R; Palafox M; Gómez-Miragaya J; González-Suárez E; Puig T
    PLoS One; 2015; 10(6):e0131241. PubMed ID: 26107737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells.
    Grunt TW; Wagner R; Grusch M; Berger W; Singer CF; Marian B; Zielinski CC; Lupu R
    Biochem Biophys Res Commun; 2009 Jul; 385(3):454-9. PubMed ID: 19467222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking fatty acid synthase inhibits tumor progression of human osteosarcoma by regulating the human epidermal growth factor receptor 2/phosphoinositide 3-kinase/protein kinase B signaling pathway in xenograft models.
    Chen XY; Ruan HB; Long XH; Peng AF; Zhou LD; Liu JM; Zhou Y; Liu ZL
    Exp Ther Med; 2017 May; 13(5):2411-2416. PubMed ID: 28565856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.